Staging chronic hepatitis C in seven categories using fibrosis biomarker (FibroTest™) and transient elastography (FibroScan®)

Journal of Hepatology

Volumn 60, Issue 4, 2014, Pages 706-714

  Poynard, Thierry ^a   Vergniol, Julien ^b,c   Ngo, Yen ^d   Foucher, Juliette ^b,c   Munteanu, Mona ^d   Merrouche, Wassil ^b,c   Colombo, Massimo ^e   Thibault, Vincent ^a   Schiff, Eugene ^f   Brass, Clifford A ^g   Albrecht, Janice K ^g   Rudler, Marika ^a   Deckmyn, Olivier ^d   Lebray, Pascal ^a   Thabut, Dominique ^a   Ratziu, Vlad ^a   De Ledinghen, Victor ^b,c  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d Biopredictive   (France)

^e UNIVERSITY OF MILAN   (Italy)

^f UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^g MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Cirrhosis complications; Elastography; Fibrosis stages; FibroTest ; Hepatocellular carcinoma; Prognostic factors; Surrogate markers

Indexed keywords

ALPHA INTERFERON; PEGINTERFERON ALPHA2B; RIBAVIRIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; ASCITES; BILE DUCT CARCINOMA; BRAIN DISEASE; CANCER INCIDENCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DECOMPENSATED LIVER CIRRHOSIS; DISEASE COURSE; DISEASE SEVERITY; ELASTOGRAPHY; ESOPHAGUS VARICES; FEMALE; FOLLOW UP; HEPATIC ENCEPHALOPATHY; HEPATITIS C; HUMAN; JAUNDICE; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FAILURE; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TRANSIENT ELASTOGRAPHY; CARCINOMA, HEPATOCELLULAR; CHRONIC HEPATITIS C; CLASSIFICATION; COHORT ANALYSIS; COMPLICATION; ESOPHAGEAL AND GASTRIC VARICES; HEPATIC INSUFFICIENCY; LIVER NEOPLASMS; PATHOLOGY; PROCEDURES; PROGNOSIS;

CARCINOMA, HEPATOCELLULAR; COHORT STUDIES; DISEASE PROGRESSION; ELASTICITY IMAGING TECHNIQUES; ESOPHAGEAL AND GASTRIC VARICES; FEMALE; HEPATIC INSUFFICIENCY; HEPATITIS C, CHRONIC; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES;

EID: 84896392780     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2013.11.016     Document Type: Article

References (33)

1. T. Poynard, P. Bedossa, and P. Opolon Natural history of liver fibrosis progression in patients with chronic hepatitis C Lancet 349 1997 825 832
2. H.H. Thein, Q. Yi, G.J. Dore, and M.D. Krahn Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: a meta-analysis and meta-regression Hepatology 48 2008 418 431
3. G. Garcia-Tsao, S. Friedman, J. Iredale, and M. Pinzani Now there are many (stages) where before there was one: in search of a pathophysiological classification of cirrhosis Hepatology 51 2010 1445 1449
4. European Association for the Study of the Liver EASL Clinical Practice Guidelines: management of hepatitis C virus infection J Hepatol 55 2011 245 264
5. T. Poynard, R. Morra, and P. Halfon et al. Meta-analyses of FibroTest™ diagnostic value in chronic liver disease BMC Gastroenterol 7 2007 40
6. R. Chou, and N. Wasson Blood tests to diagnose fibrosis or cirrhosis in patients with chronic hepatitis C virus infection: a systematic review Ann Intern Med 158 2013 807 820
7. E.A. Tsochatzis, K.S. Gurusamy, S. Ntaoula, E. Cholongitas, B.R. Davidson, and A.K. Burroughs Elastography for the diagnosis of severity of fibrosis in chronic liver disease: a meta-analysis of diagnostic accuracy J Hepatol 54 2011 650 659
8. R. Steadman, R.P. Myers, and L. Leggett et al. A health technology assessment of transient elastography in adult liver disease Can J Gastroenterol 27 2013 149 158
9. T. Poynard, Y. Ngo, and M. Munteanu et al. Biomarkers of liver injury for hepatitis clinical trials: a meta-analysis of longitudinal studies Antivir Ther 15 2010 617 631
10. T. Poynard, M. Munteanu, and O. Deckmyn et al. Validation of liver fibrosis biomarker (FibroTest™) for assessing liver fibrosis progression: proof of concept and first application in a large population J Hepatol 57 2012 541 548
11. T. Poynard, J. Moussalli, and M. Munteanu et al. Slow regression of liver fibrosis presumed by repeated biomarkers after virological cure in patients with chronic hepatitis C J Hepatol 59 2013 673 683
12. Y. Ngo, M. Munteanu, and D. Messous et al. A prospective analysis of the prognostic value of biomarkers (FibroTest™) in patients with chronic hepatitis C Clin Chem 52 2006 1887 1896
13. J. Vergniol, J. Foucher, and E. Terrebonne et al. Noninvasive tests for fibrosis and liver stiffness predict 5-year outcomes of patients with chronic hepatitis C Gastroenterology 140 2011 1970 1979
14. T. Poynard, Y. Ngo, and H. Perazzo et al. Prognostic value of liver fibrosis biomarkers: a meta-analysis Gastroenterol Hepatol (N Y) 7 2011 445 454
15. B.K. Kim, J. Fung, M.F. Yuen, and S.U. Kim Clinical application of liver stiffness measurement using transient elastography in chronic liver disease from longitudinal perspectives World J Gastroenterol 19 2013 1890 1900
16. M.A. Robic, B. Procopet, and S. Metivier et al. Liver stiffness accurately predicts portal hypertension related complications in patients with chronic liver disease: a prospective study J Hepatol 55 2011 1017 1024
17. D.A. Klibansky, S.H. Mehta, M. Curry, I. Nasser, T. Challies, and N.H. Afdhal Transient elastography for predicting clinical outcomes in patients with chronic liver disease J Viral Hepatol 19 2012 e184 e193
18. J. Bruix, T. Poynard, and M. Colombo et al. Maintenance therapy with peginterferon alfa-2b does not prevent hepatocellular carcinoma in cirrhotic patients with chronic hepatitis C Gastroenterology 140 2011 1990 1999
19. T. Poynard, M. Munteanu, and O. Deckmyn et al. Applicability and precautions of use of liver injury biomarker FibroTest™. A reappraisal at 7 years of age BMC Gastroenterol 14 2011 39
20. L. Castéra, J. Foucher, and P.H. Bernard et al. Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations Hepatology 51 2010 828 835
21. L. Castéra, J. Vergniol, and J. Foucher et al. Prospective comparison of transient elastography, FibroTest™, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C Gastroenterology 128 2005 343 350
22. T. Poynard, V. Ratziu, F. Charlotte, Z. Goodman, J. McHutchison, and J. Albrecht Rates and risk factors of liver fibrosis progression in persons with chronic hepatitis C J Hepatol 34 2001 730 739
23. Hintze J. NCSS 8; NCSS, LLC, Kaysville, Utah, USA; 2012 www.ncss.com.
24. S.K. Asrani, and P.S. Kamath Natural history of cirrhosis Curr Gastroenterol Rep 15 2013 308
25. L. Castéra, B. Le Bail, and F. Roudot-Thoraval et al. Early detection in routine clinical practice of cirrhosis and oesophageal varices in chronic hepatitis C: comparison of transient elastography (FibroScan) with standard laboratory tests and non-invasive scores J Hepatol 50 2009 59 68
26. J. Vermehren, A. Polta, and O. Zimmermann et al. Comparison of acoustic radiation force impulse imaging with transient elastography for the detection of complications in patients with cirrhosis Liver Int 32 2012 852 858
27. F. Vizzutti, U. Arena, and R.G. Romanelli et al. Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis Hepatology 45 2007 1290 1297
28. M. Lemoine, S. Katsahian, and M. Ziol et al. Liver stiffness measurement as a predictive tool of clinically significant portal hypertension in patients with compensated hepatitis C virus or alcohol-related cirrhosis Aliment Pharmacol Ther 28 2008 1102 1110
29. A. Colecchia, L. Montrone, and E. Scaioli et al. Measurement of spleen stiffness to evaluate portal hypertension and the presence of esophageal varices in patients with HCV-related cirrhosis Gastroenterology 143 2012 646 654
30. T. Poynard, V. de Ledinghen, and J.P. Zarski et al. Performances of Elasto-FibroTest™ (®), a combination between FibroTest™ (®) and liver stiffness measurements for assessing the stage of liver fibrosis in patients with chronic hepatitis C Clin Res Hepatol Gastroenterol 36 2012 455 463
31. T. Poynard, V. de Ledinghen, and J.P. Zarski et al. FibroTest™ (®) and FibroScan (®) performances revisited in patients with chronic hepatitis C. Impact of the spectrum effect and the applicability rate Clin Res Hepatol Gastroenterol 35 2011 720 730
32. T. Rath, M. Roderfeld, C. Güler, C. Wenzel, J. Graf, and F. Beitinger et al. YKL-40 and transient elastography, a powerful team to assess hepatic fibrosis Scand J Gastroenterol 46 2001 1369 1380
33. G.T. Everson, M.L. Shiffman, and J.C. Hoefs et al. Quantitative liver function tests improve the prediction of clinical outcomes in chronic hepatitis C: results from the hepatitis C antiviral long-term treatment against cirrhosis trial Hepatology 55 2012 1019 1029